Why the new AHF and PAHO HIV partnership faces a harder challenge than expanding testing
AHF and PAHO will expand early HIV testing and linkage to care as late diagnosis continues to drive preventable deaths across the region.
AHF and PAHO will expand early HIV testing and linkage to care as late diagnosis continues to drive preventable deaths across the region.
Massive Bio and GELL unite on oncology research, education and AI, but execution will determine whether the alliance expands trial access.
LATAM autoimmune care needs cheaper biologics. Polpharma Biologics and Tuteur are betting a biosimilar deal can shift access.